JP2000508665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000508665A5 JP2000508665A5 JP1997537622A JP53762297A JP2000508665A5 JP 2000508665 A5 JP2000508665 A5 JP 2000508665A5 JP 1997537622 A JP1997537622 A JP 1997537622A JP 53762297 A JP53762297 A JP 53762297A JP 2000508665 A5 JP2000508665 A5 JP 2000508665A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK49096 | 1996-04-24 | ||
| DK0490/96 | 1996-04-24 | ||
| PCT/DK1997/000184 WO1997039768A1 (en) | 1996-04-24 | 1997-04-24 | A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008145780A Division JP2008231124A (ja) | 1996-04-24 | 2008-06-03 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000508665A JP2000508665A (ja) | 2000-07-11 |
| JP2000508665A5 true JP2000508665A5 (enExample) | 2005-01-13 |
| JP4176834B2 JP4176834B2 (ja) | 2008-11-05 |
Family
ID=8094154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53762297A Expired - Lifetime JP4176834B2 (ja) | 1996-04-24 | 1997-04-24 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
| JP2008145780A Withdrawn JP2008231124A (ja) | 1996-04-24 | 2008-06-03 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008145780A Withdrawn JP2008231124A (ja) | 1996-04-24 | 2008-06-03 | 成長ホルモン、アミノ酸及び非イオン洗浄剤を含有する医薬配合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20020077461A1 (enExample) |
| EP (2) | EP1629832A1 (enExample) |
| JP (2) | JP4176834B2 (enExample) |
| KR (1) | KR20000010630A (enExample) |
| CN (1) | CN1130223C (enExample) |
| AT (1) | ATE309819T1 (enExample) |
| AU (1) | AU733592B2 (enExample) |
| BR (1) | BR9708858A (enExample) |
| CA (1) | CA2252535C (enExample) |
| CZ (1) | CZ298292B6 (enExample) |
| DE (1) | DE69734653T2 (enExample) |
| DK (1) | DK0904099T3 (enExample) |
| ES (1) | ES2253774T3 (enExample) |
| HU (1) | HU229868B1 (enExample) |
| IL (2) | IL126463A0 (enExample) |
| NO (1) | NO323360B1 (enExample) |
| PL (1) | PL188222B1 (enExample) |
| RU (1) | RU2236250C2 (enExample) |
| UA (1) | UA66758C2 (enExample) |
| WO (1) | WO1997039768A1 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981485A (en) | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| DE69722426T3 (de) | 1996-07-24 | 2015-05-07 | Warner-Lambert Company LLC (n.Ges. des Staates Delaware) | Isobutylgaba und dessen derivate zur schmerzbehandlung |
| ES2230727T3 (es) * | 1997-11-12 | 2005-05-01 | Alza Corporation | Procedimiento de administracion dermal de polipeptidos. |
| GB9803448D0 (en) * | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| JP4711520B2 (ja) * | 2000-03-21 | 2011-06-29 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| JP2004515467A (ja) | 2000-08-07 | 2004-05-27 | ネクター セラピューティックス | 吸入可能な、噴霧乾燥した、最少の凝集物を有する４−ヘリックスバンドルタンパク質粉末 |
| EP1603588A2 (en) * | 2003-03-18 | 2005-12-14 | Ares Trading S.A. | Stabilisation of growth hormones in solution |
| EP1605922A4 (en) | 2003-03-24 | 2011-03-16 | Biosphere Medical Inc | TEMPORARY EMBOLIZATION USING REVERSIBLE THERMOSENSIVE POLYMERS WITH MOMENTARY ACTION |
| DE10333317A1 (de) | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
| WO2005046438A2 (en) * | 2003-11-06 | 2005-05-26 | Pluromed, Inc. | Internal clamp for surgical procedures |
| BRPI0418115A (pt) * | 2003-12-23 | 2007-04-17 | Pharmacia Corp | formulação lìquida estável de hormÈnio de crescimento |
| JP4991522B2 (ja) * | 2004-04-07 | 2012-08-01 | アレス トレーディング ソシエテ アノニム | 成長ホルモン液剤 |
| CA2594557C (en) * | 2004-12-22 | 2016-04-26 | Ambrx, Inc. | Modified human growth hormone |
| ZA200704928B (en) * | 2004-12-22 | 2009-04-29 | Ambrx Inc | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| EP1833993A4 (en) * | 2004-12-22 | 2009-07-22 | Ambrx Inc | HUMAN GROWTH HORMONE FORMULATIONS COMPRISING AN AMINO ACID CODED NON-NATURALLY |
| WO2007025988A2 (en) | 2005-08-30 | 2007-03-08 | Novo Nordisk Health Care Ag | Liquid formulations of pegylated growth hormone |
| WO2007033427A1 (en) * | 2005-09-23 | 2007-03-29 | Metabolic Pharmaceuticals Limited | Stabilisation of peptides with basic amino acids |
| CN1939534B (zh) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
| US8409586B2 (en) | 2006-07-06 | 2013-04-02 | Daewoong Co., Ltd. | Stable liquid formulation of human growth hormone |
| AU2007271150A1 (en) | 2006-07-07 | 2008-01-10 | Novo Nordisk Health Care Ag | New protein conjugates and methods for their preparation |
| EP2120869A2 (en) * | 2006-12-18 | 2009-11-25 | Altus Pharmaceuticals Inc. | Human growth hormone formulations |
| US9211342B2 (en) | 2010-01-22 | 2015-12-15 | Novo Nordisk Healthcare Ag | Stable growth hormone compounds resistant to proteolytic degradation |
| PL2525834T3 (pl) | 2010-01-22 | 2020-10-19 | Novo Nordisk Health Care Ag | Hormony wzrostu o przedłużonej skuteczności in-vivo |
| KR101337797B1 (ko) * | 2010-07-14 | 2013-12-06 | 한미사이언스 주식회사 | 지속형 인간 성장 호르몬 결합체 액상 제제 |
| AU2011306653B2 (en) * | 2010-09-21 | 2014-06-05 | Ferring B.V. | Improved process for production of recombinant human growth hormone |
| US9216219B2 (en) | 2012-06-12 | 2015-12-22 | Novartis Ag | Anti-BAFFR antibody formulation |
| KR102427777B1 (ko) | 2012-06-26 | 2022-08-01 | 델 마 파마슈티컬스 | 디안하이드로갈락티톨, 디아세틸디안하이드로갈락티톨, 디브로모둘시톨, 또는 그의 유사체 또는 유도체를 이용하여 유전학적 다형성이 있는 환자에 있어서 티로신-키나아제-억제제 내성 악성종양, ahi1 조절곤란 또는 돌연변이를 치료하는 방법 |
| CN105120887A (zh) | 2013-04-05 | 2015-12-02 | 诺和诺德保健股份有限公司 | 生长激素化合物制剂 |
| KR20160061911A (ko) | 2013-04-08 | 2016-06-01 | 데니스 엠. 브라운 | 최적하 투여된 화학 화합물의 치료 효과 |
| KR20160099081A (ko) | 2013-07-26 | 2016-08-19 | 업데이트 파마 인코포레이트 | 비산트렌의 치료 효과 개선용 조합 방법 |
| HK1225976A1 (en) | 2013-09-27 | 2017-09-22 | Hanmi Pharm. Co., Ltd. | Sustained type human growth hormone preparation |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| MX2018011792A (es) | 2016-03-28 | 2019-07-04 | Incyte Corp | Compuestos de pirrolotriazina como inhibidores de tyro3, axl y mer (tam). |
| KR102655498B1 (ko) | 2017-09-07 | 2024-04-11 | 제이씨알 파마 가부시키가이샤 | 수성 의약 조성물 |
| TWI821200B (zh) | 2017-09-27 | 2023-11-11 | 美商英塞特公司 | Tam抑制劑之鹽 |
| SMT202500201T1 (it) | 2018-06-29 | 2025-07-22 | Incyte Corp | Formulazioni di un inibitore di axl/mer |
| IL296065A (en) | 2020-03-06 | 2022-10-01 | Incyte Corp | Combined treatment including axl/mer and pd-1/pd-l1 inhibitors |
| CN115634284B (zh) * | 2022-10-31 | 2025-02-11 | 景泽生物医药(合肥)股份有限公司 | 一种促性腺激素冻干制剂及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096885A (en) * | 1988-04-15 | 1992-03-17 | Genentech, Inc. | Human growth hormone formulation |
| CA2125855C (en) * | 1991-12-20 | 2008-05-13 | Hans Holmegaard Sorensen | A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| DK204791D0 (da) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | Hidtil ukendt farmaceutisk praeparat |
| ES2286868T3 (es) * | 1992-07-31 | 2007-12-01 | Genentech, Inc. | Composicion acuosa a base de hormana del crecimiento humana. |
-
1997
- 1997-04-23 US US08/842,293 patent/US20020077461A1/en not_active Abandoned
- 1997-04-24 AT AT97918073T patent/ATE309819T1/de active
- 1997-04-24 WO PCT/DK1997/000184 patent/WO1997039768A1/en not_active Ceased
- 1997-04-24 CN CN97194040A patent/CN1130223C/zh not_active Expired - Lifetime
- 1997-04-24 IL IL12646397A patent/IL126463A0/xx active IP Right Grant
- 1997-04-24 UA UA98105593A patent/UA66758C2/xx unknown
- 1997-04-24 DK DK97918073T patent/DK0904099T3/da active
- 1997-04-24 EP EP05110701A patent/EP1629832A1/en not_active Withdrawn
- 1997-04-24 EP EP97918073A patent/EP0904099B1/en not_active Expired - Lifetime
- 1997-04-24 KR KR1019980708535A patent/KR20000010630A/ko not_active Ceased
- 1997-04-24 AU AU26343/97A patent/AU733592B2/en not_active Expired
- 1997-04-24 BR BR9708858A patent/BR9708858A/pt not_active Application Discontinuation
- 1997-04-24 CZ CZ0320798A patent/CZ298292B6/cs not_active IP Right Cessation
- 1997-04-24 PL PL97329386A patent/PL188222B1/pl unknown
- 1997-04-24 JP JP53762297A patent/JP4176834B2/ja not_active Expired - Lifetime
- 1997-04-24 ES ES97918073T patent/ES2253774T3/es not_active Expired - Lifetime
- 1997-04-24 RU RU98121135/15A patent/RU2236250C2/ru active
- 1997-04-24 DE DE69734653T patent/DE69734653T2/de not_active Expired - Lifetime
- 1997-04-24 HU HU9902476A patent/HU229868B1/hu unknown
- 1997-04-24 CA CA002252535A patent/CA2252535C/en not_active Expired - Lifetime
-
1998
- 1998-10-04 IL IL126463A patent/IL126463A/en not_active IP Right Cessation
- 1998-10-23 NO NO19984951A patent/NO323360B1/no not_active IP Right Cessation
-
2008
- 2008-06-03 JP JP2008145780A patent/JP2008231124A/ja not_active Withdrawn